JPH203 alleviates peritoneal fibrosis via inhibition of amino acid-mediated mTORC1 signaling
Biochemical and Biophysical Research Communications · 2024-11 · 734 · 150656
DOI: 10.1016/j.bbrc.2024.150656 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024-11. Verfasst von Tiangang Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Signal Transduction, Amino Acids, Peritoneal Fibrosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Science and Technology Development Foundation.
Abstract (Originalsprache)
BACKGROUND AND AIMS: The mesothelial-mesenchymal transition (MMT) of mesothelial cells has been recognized as a critical process during progression of peritoneal fibrosis (PF). Despite its crucial role in amino acid transport and metabolism, the involvement of L-type amino acid transporter 1 (LAT1) and the potential therapeutic role of its inhibitor, JPH203, in fibrotic diseases remain unexplored. Considering the paucity of research on amino acid-mediated mTORC1 activation in PF, our study endeavors to elucidate the protective effects of JPH203 against PF and explore the involvement of amino acid-mediated mTORC1 signaling in this context. METHODS: We established the transforming growth factor beta 1 (TGF-β1) induced MMT model in primary human mesothelial cells and the peritoneal dialysis fluid (PDF) induced PF model in mice. The therapeutic effects of JPH203 on PF were then examined on these two models by real-time quantitative polymerase chain reaction, western blotting, immunofluorescence staining, Masson's trichrome staining, H&E staining, picro-sirius red staining, and immunohistochemistry. The involvement of amino acid-mediated mTORC1 signaling was screened by RNA sequencing and further verified by western blotting in vitro. RESULTS: LAT1 was significantly upregulated and JPH203 markedly attenuated fibrotic phenotype both in vitro and in vivo. RNA-seq unveiled a significant enrichment of mTOR signaling pathway in response to JPH203 treatment. Western blotting results indicated that JPH203 alleviates PF by inhibiting amino acid-mediated mTORC1 signaling, which differs from the direct inhibition observed with rapamycin. CONCLUSION: JPH203 alleviates PF by inhibiting amino acid-mediated mTORC1 signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China.
- Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
- Department of Nephrology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Electronic address: nan.zhu@shgh.cn.
- Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China; School of Pharmacy, East China Normal University, Shanghai, China. Electronic address: xuemzhang@fudan.edu.cn.
Förderung
- National Natural Science Foundation of China
- Shanghai Science and Technology Development Foundation
Zitieren
APA
Wu, T., Yu, Z., Dai, J., Li, J., Ning, F., Liu, X., Zhu, N., & Zhang, X. (2024). JPH203 alleviates peritoneal fibrosis via inhibition of amino acid-mediated mTORC1 signaling. Biochemical and Biophysical Research Communications, 734, 150656. https://doi.org/10.1016/j.bbrc.2024.150656
Vancouver
Wu T, Yu Z, Dai J, Li J, Ning F, Liu X, et al. JPH203 alleviates peritoneal fibrosis via inhibition of amino acid-mediated mTORC1 signaling. Biochemical and Biophysical Research Communications. 2024;734:150656. doi:10.1016/j.bbrc.2024.150656
BibTeX
@article{Wu2024,
author = {Wu, Tiangang and Yu, Zanzhe and Dai, Junhao and Li, Jiayang and Ning, Fengling and Liu, Xin and Zhu, Nan and Zhang, Xuemei},
title = {JPH203 alleviates peritoneal fibrosis via inhibition of amino acid-mediated mTORC1 signaling},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
volume = {734},
pages = {150656},
doi = {10.1016/j.bbrc.2024.150656}
}
EUVIMED